JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30
JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $27 to $30.
Read original at benzingaStocks · News reference
Barclays Downgrades Progyny to Equal-Weight, Raises Price Target to $34
Barclays analyst Peter Warendorf downgrades Progyny (NASDAQ:PGNY) from Overweight to Equal-Weight and raises the price target from $27 to $34.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 28, 2026, 10:55 AM
- Checked
- Jul 28, 2026, 10:55 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Wells Fargo Initiates Coverage On Progyny with Overweight Rating, Announces Price Target of $37
Wells Fargo analyst Stan Berenshteyn initiates coverage on Progyny (NASDAQ:PGNY) with a Overweight rating and announces Price Target of $37.
Read original at benzingaTruist Securities Maintains Buy on Progyny, Raises Price Target to $36
Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $33 to $36.
Read original at benzingaBarclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30
Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers the price target from $34 to $30.
Read original at benzinga